Senimed S.R.O. (Czech Republic)

Senimed S.R.O. is a Czech healthcare distribution company focused on over-the-counter products and affordable generics, positioned as a partner to pharmacies and consumer channels through broad portfolio coverage spanning medicines, supplements, medical devices and consumer healthcare. Core business segments include distribution of generic medicines and over-the-counter drugs, commercialization and distribution of food supplements, and supply of medical devices and consumer healthcare products supported by pharmacy-channel presence and direct e-commerce availability. The companys portfolio extends into cosmetic products and functional topical formats, including specialized CBD product offerings, enabling coverage across wellness, prevention, symptomatic relief and daily-care categories. Key product and brand assets within the distributed portfolio include oral probiotic and microbiota-support formats such as BAC-ENTOS and related variants, immune-support and glucan-based supplement ranges, collagen-based joint and musculoskeletal support products such as Colafit, vitamin and micronutrient products under Anixi-branded formats, and consumer health OTC products including ibuprofen-based pain and fever relief. The company also distributes and markets cosmetics and topical care products including dermatology- and sensitivity-oriented creams, nasal-support sprays and muscle and joint gels, providing a multi-category offering aligned with pharmacy and consumer-health retail demand. Geographic scope is primarily Czech Republic with distribution structured around availability through pharmacies and supported by where-to-buy navigation and an affiliated e-shop channel. Strategic focus and positioning emphasize high-quality yet accessible pricing, portfolio breadth across regulated and non-regulated consumer health categories, and strengthening retail and pharmacy-channel reach through dependable distribution and brand portfolio development within OTC, generics, supplements, devices and cosmetic healthcare segments.